AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-M 2mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Gliminyle-M 2mg/1000mg Tablet

DiaBeta-Duo 2mg/1000mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This formulation helps regulate blood glucose in diabetic patients. DiaBeta-Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with readily available glucose. Maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Gliminyle-M 2mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Gliminyle-M 2mg/1000mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gliminyle-M 2mg/1000mg tablets with food.

Common Side effects of Gliminyle-M 2mg/1000mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminyle-M 2mg/1000mg Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gliminyle-M 2mg/1000mg tablets with a meal.

How Gliminyle-M 2mg/1000mg Tablet works:

Each Gliminyle-M 2mg/1000mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two distinct antidiabetic agents. Glimepiride stimulates pancreatic insulin release to reduce blood glucose levels. Metformin acts to decrease hepatic glucose production, slow intestinal glucose uptake, and enhance insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Gliminyle-M 2mg/1000mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliminyle-M 2mg/1000mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The combination medication Gliminyle-M (2mg/1000mg tablets) is contraindicated for breastfeeding mothers. Available evidence indicates potential harm to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliminyle-M 2mg/1000mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For individuals with severe kidney disease, Gliminyle-M 2mg/1000mg tablets are contraindicated. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle-M 2mg/1000mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low Gliminyle-M 2mg/1000mg tablet dose; however, its use is contraindicated in severe liver disease.

What if you forget to take Gliminyle-M 2mg/1000mg Tablet :

Should you forget a Gliminyle-M 2mg/1000mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminyle-M 2mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminyle-M 2mg/1000mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle-M 2mg/1000mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Gliminyle-M and seek immediate medical attention.
Gliminyle-M 2mg/1000mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Gliminyle-M is not suitable for type 1 diabetes.
Gliminyle-M 2mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliminyle-M 2mg/1000mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, yearly supplemental Vitamin B12 is recommended by some researchers.
Gliminyle-M 2mg/1000mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliminyle-M 2mg/1000mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gliminyle-M 2mg/1000mg Ta...
111
MRP 135
17% off